Pliant Therapeutics

PLRX · NASDAQ

$0.9124+$0.0137 (+1.52%)TodayMarket closed ·
Prev close $0.8987

Who owns PLRX

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 45.6% of PLRX’s shares.

  • Tang Capital Management, LLC9.9%
  • Adar1 Capital Management LLC8.9%
  • Vanguard Capital Management, LLC3.9%
  • Acadian Asset Management LLC3.9%
  • Next 6 largest institutions19.0%
  • All other shareholders54.4%
Top institutional holders of PLRX
HolderShares% of shares
Tang Capital Management, LLC6.14M9.92%
Adar1 Capital Management LLC5.51M8.90%
Vanguard Capital Management, LLC2.44M3.94%
Acadian Asset Management LLC2.42M3.90%
Two Sigma Investments, LP2.26M3.65%
Citadel Advisors LLC2.14M3.46%
Renaissance Technologies LLC2.05M3.31%
Monaco asset management S.A.M.1.94M3.13%
Lynx1 Capital Advisors LLC1.80M2.90%
BML Capital Management LLC1.55M2.50%

Largest mutual fund holders

Top mutual fund holders of PLRX
HolderShares% of shares
Vanguard Total Stock Market Index Fund1.75M2.82%
Vanguard Extended Market Index Fund615.80K0.99%
Bridgeway Ultra-Small Company Fund471.33K0.76%
Sun Life Schroder Global Mid Cap Series373.60K0.60%
Fidelity Extended Market Index Fund322.27K0.52%

Insider trades

Form 4 filings by officers, directors and large holders

Insiders made no open-market buys or sales of PLRX in the last 6 months.

Latest PLRX insider transactions
InsiderTypeSharesValue
Raben DavidAward575.00K—
Borellini FlaviaAward60.00K—
Iannone RobertAward60.00K—
Krognes Steve E.Award70.00K—
Cline Darren SAward70.00K—
Curnutte John TAward70.00K—
MCCOURT Thomas AAward70.00K—
Huh HoyoungAward70.00K—
CROWELL GAYLE AAward70.00K—

Short interest

Settled Sep 30, 2026

Shares short
4.25M
Days to cover
11.40
% of shares outstanding
6.86%
Average daily volume
372.37K
Change since last report
+15.0%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.